What you'll be asked to do

The brief varies by company, but almost every MSL interview presentation falls into one of three formats:

Typical timing: 10–15 minutes presenting, 15–20 minutes Q&A. If the brief is vague, ask the recruiter to confirm the audience mix (Medical, Commercial, HR), the expected length, and whether slides will be shared in advance.

A deck structure that works

Aim for 8–12 slides. The panel is judging clarity, not slide count. This structure works for both a pivotal-paper brief and an own-research brief.

1. 1. Title & positioning (1 slide). Paper title, your name, the unmet need in one line. Set the "why this matters" before any data.
2. 2. Disease context (1 slide). Epidemiology, standard of care, where it falls short. Calibrated to the audience, assume mixed expertise.
3. 3. Study rationale (1 slide). The scientific question and the hypothesis. One sentence each.
4. 4. Design (1–2 slides). A clean schema: phase, population, randomisation, arms, primary and key secondary endpoints. Call out anything non-standard (adaptive design, crossover, biomarker enrichment).
5. 5. Primary endpoint result (1 slide). The KM curve or forest plot, the effect size with CI, the p-value. Read it out loud as you would to a KOL.
6. 6. Key secondary & subgroup data (1–2 slides).Pick the two or three that drive the clinical narrative. Don't dump every figure.
7. 7. Safety (1 slide). AESI, discontinuations, deaths. Be honest about toxicity. Panels notice when candidates skip past it.
8. 8. Strengths & limitations (1 slide). Two and two. This is where you prove you read the paper critically, not just promotionally.
9. 9. Clinical implications (1 slide). How this changes practice, or doesn't. Where it sits versus current guidelines and competitors.
10. 10. So-what for the field (1 slide). What you would discuss with a KOL on Monday morning. This is the slide that separates an MSL candidate from a researcher.

Common pitfalls

• Over-reading the slides. If the panel can read it themselves, they will. Talk to the data, don't narrate the bullets.
• No "so what". Strong scientific recall without clinical or strategic implication signals "lab scientist", not MSL.
• Ignoring the audience mix. Pitching at a PhD level when half the panel is Commercial or HR loses the room. Calibrate.
• Glossing safety. Panels probe AEs and discontinuation rates specifically because weak candidates skip them.
• Overrunning. Going 18 minutes on a 12-minute brief signals poor stakeholder discipline. Rehearse with a timer; cut, don't compress.
• Promotional framing. MSLs are non-promotional. Phrases like "best-in-class" or "the clear winner" without comparative evidence are red flags. Stick to data and limitations.
• Defensive Q&A. The panel will push on methodology. "That's a fair point, the trial didn't address X, and here's how I'd ask a KOL about it" beats defending the paper as if you wrote it.

Handling the Q&A

Q&A is usually weighted more than the presentation itself. Expected lines of attack:

• "What would you say if a KOL told you this trial doesn't reflect their real-world patients?"
• "Walk me through the limitation you're least comfortable with."
• "How does this change your conversation with a payer versus a prescriber?"
• "What's the next study you'd want to see?"
• "How would you brief a new MSL on this paper in 5 minutes?"

Answer in three beats: acknowledge the point, give the evidence, name what you'd do in the field. Silence between question and answer is fine. Panels read it as thoughtfulness, not weakness.

What a successful deck looks like

• Visual restraint. One chart per slide. No stock imagery. Company-neutral colour palette. This is a scientific exchange, not a pitch deck.
• Figures lifted directly from the paper with a citation in the footer. Don't redraw. Panels recognise the originals and trust them.
• A backup-slides section (3–5 slides): detailed methods, full subgroup tables, comparator landscape. Pull them up only when asked, proves depth without bloating the main flow.
• A clear closing slide with three takeaways phrased as you would deliver them to a KOL. Panels remember the last 60 seconds.
• References slide at the end. Five to eight citations. Signals that you read around the paper, not just the abstract.

A 7-day prep plan

1. Day 1: Pick the paper. Read it twice, once for narrative, once for methodology.
2. Day 2: Read the two highest-cited critiques or editorials. Note your honest limitations slide.
3. Day 3: Read the company's pipeline page and last earnings call. Anchor the "so what" to their strategic priorities.
4. Day 4: Draft the deck end-to-end. Don't polish, get the spine right.
5. Day 5: Rehearse twice on camera, timed. Cut anything you stumble on.
6. Day 6: Mock Q&A with a peer who'll push hard on methodology and clinical implications.
7. Day 7: Light rehearsal. Sleep. Don't redesign slides the night before.